We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (257)
- Legislation (84)
- COVID-19 (66)
- Compliance and enforcement (51)
- Vaping hub (46)
- Manufacturing (29)
- Import and export (22)
- Labelling and packaging (20)
- Medicinal cannabis hub (20)
- Scheduling (national classification system) (19)
- Safety monitoring and information (13)
- Weight loss products (6)
- Shortages and supply disruptions (4)
- Cosmetics (3)
- Committees and advisory bodies (2)
- Prescription opioids hub (2)
- Sunscreens (2)
- Unique Device Identification (UDI) hub (2)
- Clinical trials (1)
- Fees and payments (1)
- Urogynaecological (transvaginal) surgical mesh hub (1)
Search
712 result(s) found, displaying 26 to 50
-
Media releasesRobust scientific evidence shows no causal link between the use of paracetamol in pregnancy and autism or ADHD, with several large and reliable studies directly contradicting these claims.
-
Media releasesWe have issued 6 infringement notices, totalling $118,800, and a direction notice to Dispensed Pty Ltd (Dispensed) for the alleged unlawful advertising of medicinal cannabis.
-
Regulatory decision noticesInstructions for searching Australian manufacturers licensed for the manufacture of medicines, blood and biologicals.
-
Media releasesA two-day blitz on the sale of illegal vaping goods in Hobart and surrounds has resulted in seizures across 5 retail businesses for the alleged unlawful possession of commercial quantities of vaping goods and illegal tobacco.
-
Media releasesWe have issued 3 infringement notices totalling $59,400, to Victorian-based companies for the alleged unlawful advertising of therapeutic goods, in contravention of the Therapeutic Goods Act 1989.
-
Regulatory decision noticesFrom 1 September 2025, the TGA will adopt an updated version of the PIC/S Guide to GMP (PE009-17), with changes focused on Annex 1 for sterile medicines, and a phased compliance approach for manufacturers.
-
Regulatory decision noticesThe TGA has issued a direction notice to Dispensed Pty Ltd to cease advertising of medicinal cannabis on all websites, social media accounts or other advertising platforms.
-
Media releasesThe TGA, assisted by Victoria Police, seized illicit vapes worth approximately $40,000 from a retail outlet in a highly prominent location in Melbourne’s CBD.
-
Media releasesThe TGA has facilitated the seizure of millions of counterfeit and illegal therapeutic goods as part of a global initiative targeting illegal trade.
-
Media releasesThe TGA suggests extra safety measures for some sunscreen ingredients but advises Australians to keep using sunscreen. Public consultation will determine safe levels.
-
Media releasesAustralians who rely on medical devices will benefit from new measures introduced by the Australian Government to enhance the identification and management of device-related safety concerns.
-
Media releasesWe are aware that recent media reports have stated that the TGA estimates that more than 10 million vapes are sold nationally every month on the black market. These reports are incorrect.
-
Media releasesThe TGA has accepted a court-enforceable undertaking from The Aussie Gelatin Company Pty Ltd (Aussie Gelatin) in relation to the alleged unlawful manufacture, supply and advertising of therapeutic goods.
-
Media releasesWe have issued an infringement notice of $18,780 to Victorian-based company, Nourishmeorganics Pty Ltd, for the alleged unlawful supply of a therapeutic good not entered in the ARTG.
-
Atlus, Mamamia and News Life Media face court for alleged unlawful advertising of medicinal cannabis
Media releasesWe have commenced proceedings in the Federal Court of Australia against Atlus and its sole director, Mamamia, News Life and Straight Up for advertising medicinal cannabis in alleged contravention of the Therapeutic Goods Act 1989. -
Regulatory decision noticesListed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 2) 2025, which commenced on 20 June 2025.
-
Media releasesThe Therapeutic Goods Administration has commenced proceedings in the Federal Court of Australia against Philips Electronics Australia Limited (PEAL) for the alleged unlawful supply of medical devices that did not meet Australian safety and performance requirements.
-
Media releasesWe have issued 4 infringement notices totalling $75,120 to Queensland based pharmacy Summit Pharmacy Pty Ltd, for the alleged unlawful manufacturing of medicinal cannabis products.
-
Media releasesWe have accepted a court-enforceable undertaking from Your Solution Compounding Pharmacy Pty Ltd, regarding advertising of prescription-only compounded medicines for weight-loss.
-
Regulatory decision noticesUpdate on the progress in reducing the backlog of GMP Clearance Compliance Verification (CV) applications.
-
Regulatory decision noticesListed medicines indications and requirements for their use have been updated in the Therapeutic Goods (Permissible Indications) Determination (No. 1) 2025.
-
Regulatory decision noticesThis instrument is made under subsection 7C(1) of the Therapeutic Goods Act 1989.
-
Media releasesThe Therapeutic Goods Administration (TGA) has seized more than 5,000 vapes, 7,000 nicotine pouches and other products across two locations in Sydney’s western suburb of Penrith.
-
Regulatory decision noticesListed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 1) 2025, which commenced on 1 March 2025
-
Regulatory decision noticesThis instrument is made under Schedule 5A to the Therapeutic Goods Regulations 1990 and Schedule 4 to the Therapeutic Goods (Medical Devices) Regulations 2002.